At Oamaera Pharmaceuticals (OPC), we are focused on the development of a new class of drugs with precise mechanisms of action aimed at bringing innovative therapies to patients to treat diseases with significant unmet medical needs.
We believe our novel patented molecules have the potential to be developed into safe and effective pharmaceutical compounds to treat neurodegenerative and autoimmune diseases.
Clinical Pipeline
We have one of the industry’s most competitive pipelines with more than 150 projects in clinical development, our proprietary drug candidates continue to advance through various medical indications.
Technology
Our unique molecules have been rationally designed to address specific biological targets and physiological pathways validated as key targets in a wide range of diseases.
Collaborations
Oamaera Pharmaceuticals continues to establish relationships with industry leaders to further advance company research and product development practical tools to support integration.
About DHP
We use innovative science and technology to address some of society's most challenging healthcare issues and finding new ways to deliver them to as many people as possible.
Access
Our unique molecules have been rationally designed to address specific biological targets and physiological pathways validated as key targets in a wide range of diseases.
People and Culture
Oamaera Pharmaceuticals is building an Inspired, Curious and Unbossed culture to raise awareness about cultural understanding organisational healthcare quality improvement.